Skip to contentD
DNA X, Inc.
D
SONMDNA X, Inc. Q3 2022 · 10-Q
Revenue$20.50M$20.50M+41.9% vs Q3 2021 Net Income-$1.61M-$1.61MN/M vs Q3 2021 EPS Diluted-$0.04-$0.04N/M vs Q3 2021 Gross Profit$3,316,000+85.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
DNA X, Inc. · CIK 1178697 · Engraved from SEC EDGAR
Operating Cash Flowderived-$10,295,000N/M Free Cash Flowderived-$10,295,000— Margins · derivedGross margin16.2%+3.8 pt vs Q3 2021
Operating margin-9.4%+64.8 pt vs Q3 2021
Net margin-7.8%+67.9 pt vs Q3 2021
ended Sep 30, 2022 · filed Nov 14, 2022 · 45 d after period end